Lexicon Pharmaceuticals Inc
LXRX• NASDAQ
$2.00
+0.32+19.05%
In the past 24 hours
No 24-hour summary has been generated yet.
Financial highlights
Latest saved period: March 2026 · 2026-03-31
Revenue
$21.10M
Net income
-$1.04M
Free cash flow
—
Diluted EPS
—
Gross margin
99.49%
Profit margin
-4.94%
Assets
$268.82M
Cash
$38.09M
Valuation
Market Cap$888.39M
Enterprise Value$683.81M
PE (TTM)—
PE (Fwd)0.00
Price to Sales17.84
EV / EBITDA16.57
Price to Book3.95
PEG Ratio-0.14
Cash Flow
FCF Yield—
FCF / Share-$0.17
SBC-Adj FCF Yield—
SBC-Adj FCF / Share-$0.20
SBC Impact—
Margins & Growth
Gross Margin99.45%
Operating Margin-98.21%
Profit Margin-37.46%
Quarterly Rev YoY+1572.11%
Quarterly EPS YoY+95.88%
Balance
Cash$38.09M
Debt$55.65M
Net Debt$17.56M
Current Ratio18.79
Debt / Equity27.43
Dividend
Dividend Yield—
Payout Ratio—
DPS (TTM)$0.00
Last Ex-Date—
Dividend history
Cash dividends by ex-date, not an investment recommendation.
No saved cash dividend records are available for this instrument yet.
Price
-45.80%
Jul 19, 2021 - May 8, 2026 · 1,208 daily points
Revenue
↑ 130.3%Net Income
↑ 98.5%Free Cash Flow
↑ 62.8%Diluted EPS
No data
Quick Stats
Open
$1.69
Day High
$2.00
Day Low
$1.64
Prev Close
$1.68
Market Cap
—
Volume
6,974,855
Lexicon Pharmaceuticals Inc (LXRX) analysis
Wrqti brings Lexicon Pharmaceuticals Inc data into one page covering available price, financial statements, valuation ratios, margins, cash-flow metrics, news, and alerts. This page helps you understand the numbers and is not a buy or sell recommendation.
Available price
$2.00
Market cap
$888.39M
PE ratio
—
Price to book
3.95
Profit margin
-37.46%
FCF yield
—
Stocks related to Lexicon Pharmaceuticals Inc
Companies in the same sector you can compare with Lexicon Pharmaceuticals Inc: